Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × FED × Melanoma × Clear all

Phase

Status

Sponsor Class

OTHER 672 INDUSTRY 462 NIH 146 NETWORK 32 OTHER_GOV 9 UNKNOWN 3 INDIV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 29 Prostatic Neoplasms 23 Neoplasms 19 Colonic Neoplasms 12 Colonic Polyps 10 Breast Neoplasms 9 Lung Neoplasms 8 Rare Diseases 7 Heart Failure 5 Adenoma 5 Rectal Neoplasms 4 Pulmonary Disease, Chronic Obstructive 4 Ovarian Neoplasms 4 Pain 3 Mental Disorders 3 Death 3 Adenomatous Polyps 3 Urinary Incontinence 2 Sezary Syndrome 2 Respiratory Aspiration 2 Polycystic Ovary Syndrome 2 Patient Preference 2 Patient Compliance 2 Obesity 2 Neurologic Manifestations 2 Neoplasm Metastasis 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00029900 2015-03-25

ADI-PEG in Patients With Metastatic Melanoma

FDA Office of Orphan Products Development

Phase 1 Completed

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡